Recent News

• 09.24.2025 - Biogen Participating in the Bernstein 2nd Annual Healthcare Forum
• 09.24.2025 - Biogen Participating in the Bernstein 2nd Annual Healthcare Forum
• 09.17.2025 - Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
• 09.17.2025 - Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
• 09.17.2025 - Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
• 09.16.2025 - Biogen to Participate in the Bernstein 2nd Annual Healthcare Forum
• 09.16.2025 - Biogen to Participate in the Bernstein 2nd Annual Healthcare Forum
• 09.08.2025 - Biogen Participating in the Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.08.2025 - Biogen Participating in the Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.04.2025 - Biogen Participating in the Cantor Global Healthcare Conference

Recent Filings